Fidelity International’s Core Laboratories CLB Stock Holding History

Fidelity International’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-83,958	Closed	-$1.13M	–	838
2022 Q3	$1.13M	Sell	83,958 -170,489	-67%	-$2.87M	﹤0.01%	707
2022 Q2	$5.04M	Sell	254,447 -133,438	-34%	-$3.54M	0.01%	591
2022 Q1	$12.3M	Buy	387,885 +23,692	+7%	+$664K	0.01%	507
2021 Q4	$8.13M	Buy	+364,193	New	+$9.5M	0.01%	561

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Fidelity International's CLB Position: Q4 2022 in Review

Fidelity International sold out of Core Laboratories (CLB) in Q4 2022, closing a stake of 83,958 shares — an estimated $1.13M sold.

Fidelity International first reported a position in CLB in Q4 2021 and held it in 4 quarters. The position peaked at $12.3M in Q1 2022. 162 funds tracked by Wall St. Rank hold CLB as of Q4 2022.

Fidelity International reported no remaining Core Laboratories position as of Q4 2022 after selling out during the quarter.
Fidelity International sold 83,958 Core Laboratories shares in Q4 2022, an estimated $1.13M.
Fidelity International first reported a position in Core Laboratories in Q4 2021 and held it in 4 quarters.
Fidelity International's Core Laboratories position peaked at $12.3M in Q1 2022.
162 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2022.

Based on Fidelity International's 13F filing for Q4 2022, filed 13 Feb 2023.